Sustained release pharmaceutical compositions comprising a...

A - Human Necessities – 61 – K

Patent

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

A61K 31/554 (2006.01) A61K 9/26 (2006.01) A61K 9/28 (2006.01) A61K 47/38 (2006.01) A61P 25/18 (2006.01)

Patent

CA 2251944

The invention relates to sustained release formulations comprising 11-[4-[2-(2-hydroxyethoxy)ethyl]-1-piperazinyl]dibenzo[b,f][1,4]thiazepine or a pharmaceutically acceptable salt thereof, to methods of treating psychotic states and hyperactivity utilizing the sustained release formulations and to a process for preparing the sustained release formulations.

L'invention concerne des formulations à libération prolongée comprenant 11-[4-[2-(2-hydroxyéthoxy)éthyl]-1-pipérazinyl]dibenzo[b,f][1,4]thiazépine ou un sel pharmaceutiquement acceptable de celle-ci, des procédés de traitement des états psychotiques et de l'instabilité mettant en oeuvre ces formulations à libération prolongée, ainsi que leur procédé de préparation.

LandOfFree

Say what you really think

Search LandOfFree.com for Canadian inventors and patents. Rate them and share your experience with other people.

Rating

Sustained release pharmaceutical compositions comprising a... does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Sustained release pharmaceutical compositions comprising a..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Sustained release pharmaceutical compositions comprising a... will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFCA-PAI-O-1946775

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.